Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
445 |
|
| Actual shortage: | 54 (12%) | |
| Anticipated shortage: | 15 (3%) | |
| Avoided shortage: | 8 (2%) | |
| Resolved: | 368 (83%) | |
Discontinuation Reports |
68 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (75%) | |
| Reversed: | 10 (15%) | |
Late reports |
44 (9%) |
|
Overdue reports |
12 (16%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| LORAZEPAM | 1.0MG | TABLET | Resolved | 2021-03-18 | 2024-03-02 | 135885 |
| LORAZEPAM | 2.0MG | TABLET | Resolved | 2021-03-18 | 2024-03-02 | 135879 |
| FAMOTIDINE | 20MG | TABLET | Resolved | 2019-10-01 | 2020-04-29 | 95094 |
| FAMOTIDINE | 20MG | TABLET | Resolved | 2020-10-29 | 2024-03-02 | 127488 |
| FAMOTIDINE | 40MG | TABLET | Resolved | 2019-10-01 | 2020-04-29 | 95100 |
| FAMOTIDINE | 40MG | TABLET | Resolved | 2020-10-29 | 2020-12-11 | 127491 |
| FAMOTIDINE | 40MG | TABLET | Resolved | 2021-08-12 | 2024-03-02 | 144050 |
| FUROSEMIDE | 20MG | TABLET | Resolved | 2023-03-16 | 2023-07-06 | 187311 |
| FUROSEMIDE | 20MG | TABLET | Resolved | 2023-07-31 | 2023-10-23 | 200426 |
| FUROSEMIDE | 80MG | TABLET | Resolved | 2023-03-16 | 2023-07-06 | 187306 |
| LEFLUNOMIDE | 10MG | TABLET | Resolved | 2019-03-29 | 2019-07-06 | 79973 |
| LEFLUNOMIDE | 10MG | TABLET | Resolved | 2023-07-05 | 2023-09-25 | 197620 |
| LEFLUNOMIDE | 20MG | TABLET | Resolved | 2023-07-05 | 2023-11-06 | 197624 |
| DICLOFENAC K | 50MG | TABLET | Resolved | 2019-08-07 | 2024-03-02 | 91112 |
| ALENDRONATE | 70MG | TABLET | Resolved | 2017-06-06 | 2018-05-26 | 12091 |
| ALENDRONATE | 70MG | TABLET | Resolved | 2017-09-13 | 2018-05-26 | 21985 |
| ALENDRONATE | 70MG | TABLET | Resolved | 2021-11-17 | 2022-07-06 | 149505 |
| ALENDRONATE | 70MG | TABLET | Resolved | 2022-01-19 | 2022-07-06 | 153051 |
| ALENDRONATE | 70MG | TABLET | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223355 |
| ALENDRONATE | 70MG | TABLET | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223392 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
| DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
| DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
| MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-04-08 | 2020-06-13 | 111515 |
| MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-04-08 | 111518 |
| MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-06-03 | 111521 |
| BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151302 |
| BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151307 |